Rathbones Group PLC Cuts Stock Position in Xylem Inc. $XYL

Rathbones Group PLC lessened its position in shares of Xylem Inc. (NYSE:XYL) by 5.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 341,065 shares of the industrial products company’s stock after selling 18,092 shares during the quarter. Rathbones Group PLC’s holdings in Xylem were worth $40,757,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. J. Stern & Co. LLP boosted its stake in Xylem by 12,326.6% in the fourth quarter. J. Stern & Co. LLP now owns 45,448,168 shares of the industrial products company’s stock valued at $6,189,132,000 after acquiring an additional 45,082,435 shares in the last quarter. Norges Bank acquired a new position in shares of Xylem during the fourth quarter worth $361,012,000. SEB Asset Management AB acquired a new position in shares of Xylem during the first quarter worth $66,700,000. Balyasny Asset Management L.P. lifted its holdings in shares of Xylem by 346.2% during the 3rd quarter. Balyasny Asset Management L.P. now owns 712,950 shares of the industrial products company’s stock valued at $105,160,000 after purchasing an additional 553,152 shares during the last quarter. Finally, Adage Capital Partners GP L.L.C. purchased a new stake in shares of Xylem during the 2nd quarter valued at $64,407,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Xylem Price Performance

NYSE XYL opened at $117.29 on Monday. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.61 and a quick ratio of 1.24. The stock’s fifty day moving average price is $115.23 and its 200 day moving average price is $122.01. Xylem Inc. has a 1 year low of $105.29 and a 1 year high of $154.27. The company has a market cap of $27.39 billion, a price-to-earnings ratio of 27.93, a PEG ratio of 1.62 and a beta of 1.02.

Xylem (NYSE:XYL) last issued its quarterly earnings results on Tuesday, July 28th. The industrial products company reported $1.46 EPS for the quarter, topping analysts’ consensus estimates of $1.34 by $0.12. The company had revenue of $2.34 billion during the quarter, compared to analysts’ expectations of $2.34 billion. Xylem had a return on equity of 11.77% and a net margin of 11.15%.The firm’s revenue was up 1.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.26 EPS. Xylem has set its FY 2026 guidance at 5.550-5.700 EPS. As a group, equities research analysts forecast that Xylem Inc. will post 5.67 earnings per share for the current year.

Xylem Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Thursday, May 28th were issued a dividend of $0.43 per share. The ex-dividend date of this dividend was Thursday, May 28th. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.5%. Xylem’s payout ratio is 40.95%.

Insider Activity at Xylem

In related news, CAO Geri-Michelle Mcshane sold 4,269 shares of the company’s stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $117.46, for a total value of $501,436.74. Following the sale, the chief accounting officer owned 3,605 shares in the company, valued at $423,443.30. This represents a 54.22% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.32% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on XYL. Oppenheimer dropped their target price on Xylem from $160.00 to $158.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 29th. UBS Group increased their price target on Xylem from $129.00 to $135.00 and gave the company a “neutral” rating in a research note on Thursday. Royal Bank Of Canada raised their price target on Xylem from $159.00 to $164.00 and gave the stock an “outperform” rating in a report on Wednesday, July 29th. JPMorgan Chase & Co. dropped their price target on Xylem from $170.00 to $160.00 and set an “overweight” rating on the stock in a research note on Thursday, April 16th. Finally, Mizuho upped their price objective on shares of Xylem from $124.00 to $130.00 and gave the company a “neutral” rating in a report on Wednesday. Nine equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $154.00.

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.